Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience
Therap Clinil Risk Manag
They deliver clinically proven results, often with significant weight loss outcomes in medical trials
At Montare Behavioral Health, we know how dangerous self-medicating can be, both physically and psychologically, and were committed to helping people make informed, safe choices for their health
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are indicated in type 2 diabetes and obesity for their high efficacy in controlling glycaemia and inducing body weight loss, respectively
For instance, exendin-4 has been shown to ameliorate the high glucose-induced fibronectin (FN) and type I collagen (Col1) expression in tubular epithelial cells by inhibiting the secretion of miR-192, an microRNA (miRNA) that is regulated by p53 and plays a role in renal fibrosis (Yin et al., 2018)